Oral pH-modified release budesonide for treatment of inflammatory bowel disease, collagenous and lymphocytic colitis

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.7, 2008-05, pp. : 1257-1265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Budesonide beneficial in collagenous colitis

Inpharma, Vol. 1, Iss. 1368, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Budesonide: Teaching an Old Dog New Tricks for Inflammatory Bowel Disease Treatment

Current Medicinal Chemistry, Vol. 15, Iss. 24, 2008-10 ,pp. : 2527-2535

Bentham Science Publishers

Access to resources Recommend Favorite

Mesalazine for the treatment of inflammatory bowel disease

By Criscuoli Valeria

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1669-1678

Informa Healthcare

Access to resources Recommend Favorite

Thiopurine Treatment in Inflammatory Bowel Disease

By Gardiner Sharon J.

Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. : 803-804

Adis International

Access to resources Recommend Favorite

Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis

Current Pharmaceutical Design, Vol. 22, Iss. 2, 2016-01 ,pp. : 180-188

Bentham Science Publishers

Access to resources Recommend Favorite